Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Veterinary Point of Care Diagnostics Market Size & Growth Forecast 2026–2035, By Segments (Animal Type, End-use, Product, Sample Type, Testing Category, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 14692| Published Date: Jun-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Veterinary Point of Care Diagnostics Market size stood at USD 2.31 Billion in 2025 and is predicted to grow at a 11.4% CAGR from 2026 to 2035, exceeding USD 6.8 Billion by 2035. The industry revenue for 2026 is estimated at USD 2.55 billion.

Base Year Value (2025)
USD 2.31 Billion
CAGR (2026-2035)
11.4%
Forecast Year Value (2035)
USD 6.8 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Veterinary Point of Care Diagnostics Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 50.77% share in 2025, supported by established veterinary infrastructure and routine use of rapid in-clinic diagnostics for treatment decisions and wellness monitoring.
  • Asia Pacific is expected to grow at a 12.77% CAGR as clinics adopt compact on-site diagnostic systems, improving disease detection, clinical decision-making, and access to veterinary care.

Segment Momentum

  • Companion Animals held a 62.99% share in 2025 because frequent veterinary visits and the need for immediate diagnostic results support rapid treatment decisions and ongoing preventive care.
  • Home Care Settings are growing fastest as pet owners increasingly adopt convenient monitoring solutions that reduce clinic visits while supporting timely health checks and continuous animal care.

Market Expansion Drivers

  • Rising companion animal healthcare spending driving rapid adoption of in-clinic diagnostic testing.
  • Increasing zoonotic disease monitoring accelerating livestock and public health diagnostic deployment.
  • Expansion of pet insurance and decentralized veterinary care enabling routine rapid diagnostics.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Leading players in the veterinary point of care diagnostics market include IDEXX Laboratories, Inc. (United States), Zoetis Inc. (United States), Virbac S.A. (France), Thermo Fisher Scientific Inc. (United States), FUJIFILM Holdings Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Woodley Equipment Company Ltd. (United Kingdom), Getein Biotech, Inc. (China), Randox Laboratories Ltd. (United Kingdom).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising companion animal healthcare spending driving rapid adoption of in-clinic diagnostic testing

Higher spending on pets is changing how veterinary practices approach diagnosis, with owners increasingly willing to authorize tests during the initial visit rather than delay decisions or rely on symptom-based treatment. In the veterinary point of care diagnostics market, this behavior supports stronger uptake of in-clinic analyzers, rapid assay kits, and consumables because clinics can convert more consultations into immediate testing for conditions such as infections, metabolic disorders, and organ function abnormalities. As companion animal care becomes more preventive and treatment expectations rise, practices also invest in broader diagnostic menus and faster turnaround capabilities, reinforcing recurring demand tied to routine wellness screening as well as acute care.

Increasing zoonotic disease monitoring accelerating livestock and public health diagnostic deployment

Closer surveillance of animal-to-human disease transmission is pushing farms, veterinary networks, and public health agencies toward faster testing at the site of care, where early detection directly affects containment decisions and herd management. This dynamic is strengthening market development in the veterinary point of care diagnostics market by increasing demand for portable, easy-to-use systems that can identify infectious threats without waiting for centralized laboratory results. The practical effect is a greater emphasis on field-deployable diagnostics in livestock settings, where testing speed influences quarantine actions, animal movement decisions, and outbreak response protocols tied to food safety and regional biosecurity.

Expansion of pet insurance and decentralized veterinary care enabling routine rapid diagnostics

As pet insurance reduces out-of-pocket friction, veterinarians face fewer barriers when recommending immediate diagnostic workups, making rapid testing a more routine part of clinical decision-making rather than an optional add-on. At the same time, decentralized care models such as small-format clinics, mobile practices, and urgent care centers depend on compact diagnostic tools that deliver actionable results during a single encounter. In the veterinary point of care diagnostics market, these two shifts work together to increase market penetration for portable platforms and cartridge-based tests, since dispersed care settings need efficient on-site diagnostics to manage caseloads without the infrastructure or delays associated with reference laboratories.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Growing demand for veterinary point-of-care diagnostics 4.00% Short term (≤ 2 yrs) North America, Europe (spillover: Asia Pacific) Medium Fast
Adoption in livestock and companion animal health monitoring 3.50% Medium term (2–5 yrs) Europe, Asia Pacific (spillover: North America) Medium Moderate
Expansion of portable and rapid diagnostic devices 2.90% Long term (5+ yrs) North America, Europe (spillover: Asia Pacific) Medium Slow
Rising companion animal healthcare spending driving rapid adoption of in-clinic diagnostic testing 2.10% Moderate North America, Europe High Near Term
Increasing zoonotic disease monitoring accelerating livestock and public health diagnostic deployment 1.80% High Asia Pacific, North America High Mid Term
Expansion of pet insurance and decentralized veterinary care enabling routine rapid diagnostics 1.50% Moderate North America, Europe, Asia Pacific High Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
50.77% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading position in 2025, accounting for a 50.77% share of the veterinary point of care diagnostics market. Its leadership is bolstered by the routine use of rapid in-clinic testing across companion animal care, where veterinarians rely on immediate diagnostic results to guide treatment decisions during the same visit. This practical workflow advantage is strengthened by established veterinary care infrastructure, higher testing adoption in animal hospitals and clinics, and consistent utilization of point-of-care tools for blood analysis, infectious disease screening, and wellness monitoring.

Asia Pacific is projected to expand at a 12.77% CAGR over the forecast period in the veterinary point of care diagnostics market, driven by rising uptake of faster diagnostic methods in veterinary settings as animal care access broadens across the region. Growth is being impelled by increasing demand for timely disease detection and treatment support, particularly as clinics and hospitals incorporate compact, on-site diagnostic systems that reduce dependence on centralized laboratories. Wider adoption in everyday practice is accelerating regional momentum as providers seek quicker clinical decision-making and more efficient patient management.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Precision Diagnostic Adoption

Germany emphasizes high-accuracy diagnostic solutions for both companion and production animals. Veterinary practices in Germany are increasingly integrating in-clinic testing systems that support disease screening and preventive care while reducing dependence on centralized laboratories.

France 🇫🇷

Preventive Animal Health Focus

France is increasingly using point-of-care diagnostics to strengthen preventive veterinary care and disease surveillance. Veterinary practices in France are seeking versatile testing platforms capable of supporting routine wellness screening and timely identification of infectious conditions.

Italy 🇮🇹

Expanding Clinic Capabilities

Italy is seeing broader deployment of in-house diagnostic systems as veterinary clinics seek faster clinical insights and improved patient management. The Italian market is characterized by interest in cost-effective testing solutions that can support both companion animal and livestock applications.

Japan 🇯🇵

Aging Pet Management

Japan's growing focus on managing chronic conditions in aging pets is supporting demand for accessible diagnostic tools. Veterinary clinics in Japan are prioritizing point-of-care systems that enable routine monitoring of metabolic and infectious diseases during a single patient visit.

South Korea 🇰🇷

Digitally Connected Clinics

South Korea is adopting veterinary diagnostic platforms that combine rapid testing with digital record management. The country's expanding pet healthcare sector is encouraging clinics to invest in compact diagnostic equipment that enhances service efficiency and supports preventive medicine programs.

United States 🇺🇸

Companion Care Innovation

The U.S. veterinary point of care diagnostics market is benefiting from rising demand for rapid testing in companion animal clinics and emergency settings. Veterinary providers in the U.S. are adopting portable analyzers and digital diagnostic platforms to improve clinical decision-making and treatment turnaround times.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Veterinary Point of Care Diagnostics Market Share (%), Animal Type, 2025

Companion Animals
Livestock Animals

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Animal Type Segment Analysis: Companion Animals (Largest Segment) vs Livestock Animals (Fastest-Growing Segment)

Companion Animals held a 62.99% share of the veterinary point of care diagnostics market in 2025, reflecting the segment’s established position across routine and urgent care settings. This leadership is underpinned by the high frequency of clinical visits for pets, where rapid diagnostic decisions are central to managing infections, chronic diseases, and preventive care. The veterinary point of care diagnostics market continues to see strong use in companion animal practice because pet owners and clinicians often prioritize immediate test results that support same-visit treatment decisions and ongoing monitoring.

Livestock Animals are emerging as the fastest-growing segment in the veterinary point of care diagnostics market as animal health management becomes more time-sensitive and operationally driven in production settings. Growth is being aided by the need for faster disease detection at or near the site of care, where delays can affect herd health, productivity, and farm-level decision-making. Compared with companion animal care, the momentum in livestock animal diagnostics is tied more directly to the practical value of rapid testing in managing larger populations efficiently and reducing the impact of disease spread.

End-use Segment Analysis: Veterinary Hospitals & Clinics (Largest Segment) vs Home Care Settings (Fastest-Growing Segment)

Veterinary Hospitals & Clinics accounted for the largest share of the veterinary point of care diagnostics market in 2025, aided by their role as the primary setting for diagnostic evaluation, treatment planning, and follow-up care. Their leadership comes from the concentration of trained professionals, established testing workflows, and access to a broad range of point-of-care tools that can be used immediately during consultations. In the veterinary point of care diagnostics market, these facilities remain the core demand center because they handle the highest volume of cases requiring timely clinical assessment and rapid interpretation of results.

Home Care Settings are the fastest-growing end-use segment in the veterinary point of care diagnostics market as pet care increasingly extends beyond conventional clinical environments. Growth is being driven by rising interest in convenient monitoring approaches that reduce the need for repeated facility visits while still supporting timely health checks. Relative to hospitals and clinics, home care settings are gaining momentum where simpler diagnostic use cases can fit into ongoing animal management, especially when speed, accessibility, and continuity of observation matter most.

Segment Sub-Segment Largest Segment Fastest Growing
Animal Type Companion Animals, Livestock Animals Companion Animals Livestock Animals
End-use Veterinary Hospitals & Clinics, Home Care Settings, Others Veterinary Hospitals & Clinics Home Care Settings
Product Consumables, Reagents, & Kits, Instruments & Devices Consumables, Reagents, & Kits Instruments & Devices
Sample Type Blood/Plasma/Serum, Urine, Fecal, Others Blood/Plasma/Serum Urine
Testing Category Hematology, Diagnostic Imaging, Bacteriology, Virology, Cytology, Clinical Chemistry, Parasitology, Serology, Others Parasitology Hematology
Indication Infectious Disease, General Ailments, Others Infectious Disease Infectious Disease
Competitive Landscape

Competitive Landscape and Market Positioning

Key companies in the veterinary point of care diagnostics market:

1. IDEXX Laboratories Inc. (United States)

2. Zoetis Inc. (United States)

3. Virbac S.A. (France)

4. Thermo Fisher Scientific Inc. (United States)

5. FUJIFILM Holdings Corporation (Japan)

6. Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)

7. Woodley Equipment Company Ltd. (United Kingdom)

8. Getein Biotech Inc. (China)

9. Randox Laboratories Ltd. (United Kingdom)

Rapid advances in diagnostic technologies are supporting the veterinary point of care diagnostics market, with increasing integration of portable analyzers, AI-assisted interpretation, and digital connectivity. Product innovation is enabling faster clinical decision-making and improving animal healthcare outcomes.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Zoetis Apr-26 Zoetis expanded the capabilities of its Vetscan OptiCell point-of-care hematology analyzer by adding new diagnostic parameters, including CHCM and PCT. The enhancement strengthens in-clinic blood analysis by providing more comprehensive real-time hematology insights, reinforcing the company's position in veterinary point-of-care diagnostics.
bioMérieux Jun-25 bioMérieux launched VETFIRE, a ready-to-use PCR diagnostic kit for equine infectious respiratory diseases capable of simultaneously detecting seven respiratory pathogens. The launch expands the company's veterinary point-of-care infectious disease testing portfolio with a specialized molecular diagnostic solution for equine healthcare.
IDEXX Laboratories Jun-25 IDEXX Laboratories introduced IDEXX Cancer Dx, a canine lymphoma diagnostic panel priced at USD 15 that delivers results within two to three days. The launch expands the company's veterinary oncology diagnostics portfolio and strengthens access to rapid cancer testing for companion animals.
Antech Diagnostics Mar-25 Antech Diagnostics launched truRapid FOUR, an in-house canine vector-borne disease screening test capable of detecting antibodies to Anaplasma spp., Ehrlichia spp., Lyme C6 and heartworm antigen. The product broadens rapid in-clinic diagnostic capabilities for veterinary practices.
Zoetis Jan-25 Zoetis introduced the AI-powered Vetscan OptiCell, a cartridge-based, screenless point-of-care hematology analyzer delivering complete blood count results with reference laboratory-quality accuracy within minutes. The launch advances AI adoption in veterinary diagnostics while improving workflow efficiency in clinics.
Zoetis Jan-25 Zoetis unveiled AI Masses for its Vetscan Imagyst platform, enabling rapid lesion screening with a commercial rollout planned for the second quarter of 2025. The addition expands AI-enabled diagnostic capabilities and strengthens the company's veterinary point-of-care imaging portfolio.
Mars Petcare Jun-23 Mars Petcare acquired Heska to expand its veterinary point-of-care diagnostics capabilities and strengthen its diagnostic product portfolio. The acquisition enhances the company's market presence by broadening access to integrated animal diagnostic solutions.
VolitionRx Limited Mar-22 VolitionRx signed an exclusive global supply and licensing agreement with Heska Corporation to commercialize the Nu.Q Vet Cancer Screening test. The agreement expands global distribution opportunities for veterinary cancer diagnostics and strengthens the companies' long-term collaboration.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Veterinary Point of Care Diagnostics Market — Custom Segments

Segment Sub-Segment
No segment data available.

Veterinary Point of Care Diagnostics Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the current revenue of the veterinary point of care diagnostics market?

As of 2026 the market size of veterinary point of care diagnostics is valued at USD 2.55 billion.

What is the projected value of the veterinary point of care diagnostics industry by 2035?

Veterinary Point Of Care Diagnostics Market size is likely to expand from USD 2.31 billion in 2025 to USD 6.8 billion by 2035 posting a CAGR above 11.4% across 2026-2035.

How is rising companion animal healthcare spending shaping the adoption of in-clinic point-of-care diagnostics?

Higher pet healthcare spending is increasing willingness to conduct diagnostics during initial visits, enabling immediate testing and treatment decisions. Clinics are expanding rapid testing capabilities, supporting routine screening and faster clinical intervention in companion animal care.

What is driving the increasing role of point-of-care diagnostics in livestock and zoonotic disease management?

Faster on-site testing is becoming critical for herd health management and disease containment. It supports quicker decisions on quarantine, movement control, and outbreak response, strengthening biosecurity and operational efficiency in livestock systems.

Why are companion animals the largest animal type segment in the veterinary point of care diagnostics market?

Companion Animals held a 62.99% share in 2025 because frequent veterinary visits and the need for immediate diagnostic results support rapid treatment decisions and ongoing preventive care.

Why are home care settings the fastest-growing end-use segment in the veterinary point of care diagnostics market?

Home Care Settings are growing fastest as pet owners increasingly adopt convenient monitoring solutions that reduce clinic visits while supporting timely health checks and continuous animal care.

Why is North America the leading veterinary point of care diagnostics market?

North America held a 50.77% share in 2025, supported by established veterinary infrastructure and routine use of rapid in-clinic diagnostics for treatment decisions and wellness monitoring.

What is driving veterinary point of care diagnostics growth in Asia Pacific?

Asia Pacific is expected to grow at a 12.77% CAGR as clinics adopt compact on-site diagnostic systems, improving disease detection, clinical decision-making, and access to veterinary care.

Which companies are driving growth in the veterinary point of care diagnostics landscape?

Leading players in the veterinary point of care diagnostics market include IDEXX Laboratories, Inc. (United States), Zoetis Inc. (United States), Virbac S.A. (France), Thermo Fisher Scientific Inc. (United States), FUJIFILM Holdings Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Woodley Equipment Company Ltd. (United Kingdom), Getein Biotech, Inc. (China), Randox Laboratories Ltd. (United Kingdom).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →